RADIANCE CED: long-term outcomes after ultrasound renal denervation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

RADIANCE CED is a prospective observational study that collects electronic health record data from Medicare-eligible patients who underwent ultrasound renal denervation to track long-term blood pressure changes. The study focuses on adults aged 65 and older who have uncontrolled hypertension and are on a stable regimen of blood-pressure medications. Key exclusions include secondary hypertension, prior renal denervation, pregnancy, and end-stage renal disease or dialysis. The sponsor has obtained IRB exemption and individual hospital enrollment is not required, with data drawn to support generalizability to the broader Medicare population.

Why it matters

Who can join: the full rules

Common Inclusion Criteria:

* Adults aged ≥65 years with uncontrolled hypertension
* Stable regimen of blood pressure-lowering medication

Common Exclusion Criteria:

* Hypertension due to secondary causes
* Prior renal denervation treatment
* Pregnancy
* End-stage renal disease, dialysis, or kidney transplant

Where it's running

• Henry Ford Hospital
  Detroit, Michigan, United States Recruiting
• Henry Ford St. John Hospital
  Detroit, Michigan, United States Recruiting

Study contacts

• Principal investigator: Megan Coylewright, MD — Essentia Health
• Study coordinator: Helen Reeve-Stoffer, Ph.D
• Email: hreeve-stoffer@recormedical.com
• Phone: 650-542-7700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• Pulmonary Artery Denervation for a specific type of heart and lung pressure problem

  This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.

  Recruiting at 18 sites Pulnovo Medical, Inc. · Tucson, Arizona and 18 other locations · NCT07214376

• Long-term outcomes of Symplicity renal denervation for uncontrolled hypertension in Medicare patients

  This project will see if adding the Symplicity renal denervation procedure to usual care lowers blood pressure over two years in Medicare patients with uncontrolled hypertension.

  Recruiting Medtronic Vascular · Boston, Massachusetts · NCT07174622

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• Spyral InSight: renal nerve stimulation before and after renal denervation

  This study will test whether stimulating the nerves of the kidney before and after renal denervation is safe and how it changes blood pressure in adults 20–70 with moderately uncontrolled hypertension on 1–3 medications.

  Recruiting at 2 sites Medtronic Vascular · Athens and 1 other locations · NCT07013929

• Gemini multi-organ denervation for uncontrolled high blood pressure

  The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.

  Recruiting at 18 sites Medtronic Vascular · Stanford, California and 17 other locations · NCT06907147

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.